3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Status
Recruiting
11
Active not recruiting
8
Completed
6
Not yet recruiting
3
Enrolling by invitation
3
Terminated
1
Sponsor Class
OTHER
3
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
2
Lymphoid
1
Conditions
Breast Neoplasms
152
Neoplasms
108
Carcinoma, Non-Small-Cell Lung
83
Colorectal Neoplasms
81
Prostatic Neoplasms
80
Lung Neoplasms
71
Leukemia, Myeloid, Acute
48
Carcinoma, Hepatocellular
48
Pancreatic Neoplasms
45
Neoplasm Metastasis
39
Multiple Myeloma
37
Recurrence
34
Triple Negative Breast Neoplasms
29
Squamous Cell Carcinoma of Head and Neck
27
Precursor Cell Lymphoblastic Leukemia-Lymphoma
27
Melanoma
27
Glioblastoma
27
Head and Neck Neoplasms
25
Brain Neoplasms
25
Uterine Cervical Neoplasms
24
Stomach Neoplasms
24
Rectal Neoplasms
24
Ovarian Neoplasms
24
Small Cell Lung Carcinoma
22
Carcinoma, Renal Cell
20
Lymphoma, B-Cell
19
Lymphoma, Follicular
18
Lymphoma
18
Endometrial Neoplasms
18
Glioma
17
Interventions
Quality of Life
1
Electrocardiography
1
Complementary Therapies
1
Clinical Laboratory Techniques
1
Bone Marrow Examination
1
Azacitidine
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Hematologic Diseases
×
90 days
×
Clear all
NCT07541326
2026-04-21
COMPLHEMATO
University Hospital, Limoges
Phase NA
Not yet recruiting
85 enrolled
NCT05969821
2026-03-23
CHIS
Assistance Publique - Hôpitaux de Paris
Not yet recruiting
5,000 enrolled
NCT07387354
2026-03-16
MDS
Thomas Jefferson University
Phase 1/2
Not yet recruiting
25 enrolled